Neurogene (NGNE) Income from Continuing Operations (2018 - 2025)
Historic Income from Continuing Operations for Neurogene (NGNE) over the last 5 years, with Q3 2025 value amounting to -$21.1 million.
- Neurogene's Income from Continuing Operations fell 365.48% to -$21.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$86.8 million, marking a year-over-year decrease of 2393.35%. This contributed to the annual value of -$75.7 million for FY2024, which is 4376.38% down from last year.
- As of Q3 2025, Neurogene's Income from Continuing Operations stood at -$21.1 million, which was down 365.48% from -$23.2 million recorded in Q2 2025.
- Neurogene's Income from Continuing Operations' 5-year high stood at -$11.9 million during Q2 2023, with a 5-year trough of -$23.2 million in Q2 2025.
- Over the past 3 years, Neurogene's median Income from Continuing Operations value was -$18.6 million (recorded in 2024), while the average stood at -$17.8 million.
- As far as peak fluctuations go, Neurogene's Income from Continuing Operations crashed by 5713.92% in 2024, and later plummeted by 365.48% in 2025.
- Quarter analysis of 3 years shows Neurogene's Income from Continuing Operations stood at -$14.0 million in 2023, then tumbled by 40.71% to -$19.7 million in 2024, then decreased by 7.35% to -$21.1 million in 2025.
- Its Income from Continuing Operations was -$21.1 million in Q3 2025, compared to -$23.2 million in Q2 2025 and -$22.8 million in Q1 2025.